To further investigate the effect of BC tumor cells on SMAD signaling, we performed immunostaining for phosphorylated SMAD2 (p-SMAD2) in in vitro differentiated WT OCs treated with 10% CM derived from 4T1 or MDA cells (Fig. 8A). Here, SMAD2 is linked to breast cancer.